Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification

被引:1
作者
Houlind, Morten Baltzer [1 ,2 ,3 ,4 ,14 ]
Hansen, Luise [1 ,4 ]
Iversen, Esben [1 ]
Rasmussen, Henrik Berg [5 ]
Larsen, Jens Borggaard [6 ]
Jorgensen, Steffen [7 ]
Dalhoff, Kim [8 ,9 ]
Damkier, Per [10 ,11 ]
Walls, Anne B. [3 ,4 ]
Vermehren, Charlotte [3 ,4 ]
Andersen, Trine Rune Hogh [12 ]
Kallemose, Thomas [1 ]
Christrup, Lona [4 ]
Westergaard, Niels [13 ]
机构
[1] Copenhagen Univ Hosp Amager & Hvidovre, Dept Clin Res, Hvidovre, Denmark
[2] Copenhagen Univ Hosp Amager & Hvidovre, Emergency Dept, Hvidovre, Denmark
[3] Capital Reg Pharm, Herlev, Denmark
[4] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark
[5] Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, Roskilde, Denmark
[6] Danish Epilepsy Ctr Filadelfia, Dianalund, Denmark
[7] Univ Coll Absalon, Ctr Engn & Sci, Naestved, Denmark
[8] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Clin Pharmacol, Copenhagen, Denmark
[9] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[10] Odense Univ Hosp, Dept Clin Pharmacol, Odense, Denmark
[11] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[12] Reg Zealand Hosp Pharm, Roskilde, Denmark
[13] Univ Coll Absalon, Ctr Nursing, Roskilde, Denmark
[14] Kettegaard Alle 30, DK-2650 Hvidovre, Denmark
关键词
genotype; genotype-phenotype association; pharmacogenomics; phenotype;
D O I
10.1111/bcpt.13990
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:756 / 763
页数:8
相关论文
共 22 条
[1]   Optimization of Nutrition And Medication (OptiNAM) for acutely admitted older patients: protocol for a randomized single-blinded controlled trial [J].
Andersen, Aino L. ;
Houlind, Morten B. ;
Nielsen, Rikke L. ;
Jorgensen, Lillian M. ;
Treldal, Charlotte ;
Damgaard, Morten ;
Bengaard, Anne Kathrine ;
Juul-Larsen, Helle Gybel ;
Laursen, Louise Bolvig ;
Iversen, Esben ;
Kruse, Marie ;
Pedersen, Anne M. L. ;
Hornum, Mads ;
Beck, Anne M. ;
Pedersen, Mette M. ;
Ankarfeldt, Mikkel Z. ;
Petersen, Janne ;
Andersen, Ove .
TRIALS, 2021, 22 (01)
[2]  
[Anonymous], CPIC GUIDELINE CLOPI
[3]  
[Anonymous], CPIC GUIDELINE PROTO
[4]   Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants [J].
Bousman, Chad A. ;
Stevenson, James M. ;
Ramsey, Laura B. ;
Sangkuhl, Katrin ;
Hicks, J. Kevin ;
Strawn, Jeffrey R. ;
Singh, Ajeet B. ;
Ruano, Gualberto ;
Mueller, Daniel J. ;
Tsermpini, Evangelia Eirini ;
Brown, Jacob T. ;
Bell, Gillian C. ;
Leeder, J. Steven ;
Gaedigk, Andrea ;
Scott, Stuart A. ;
Klein, Teri E. ;
Caudle, Kelly E. ;
Bishop, Jeffrey R. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (01) :51-68
[5]   Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools [J].
Bousman, Chad A. ;
Dunlop, Boadie W. .
PHARMACOGENOMICS JOURNAL, 2018, 18 (05) :613-622
[6]   Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) [J].
Caudle, Kelly E. ;
Dunnenberger, Henry M. ;
Freimuth, Robert R. ;
Peterson, Josh F. ;
Burlison, Jonathan D. ;
Whirl-Carrillo, Michelle ;
Scott, Stuart A. ;
Rehm, Heidi L. ;
Williams, Marc S. ;
Klein, Teri E. ;
Relling, Mary V. ;
Hoffman, James M. .
GENETICS IN MEDICINE, 2017, 19 (02) :215-223
[7]   INTEGRATION AND GENERALIZATION OF KAPPAS FOR MULTIPLE RATERS [J].
CONGER, AJ .
PSYCHOLOGICAL BULLETIN, 1980, 88 (02) :322-328
[8]  
Dawes Martin, 2016, CMAJ Open, V4, pE528
[9]  
Filadelfia, CYP2C19
[10]   Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects [J].
Ingelman-Sundberg, Magnus ;
Sim, Sarah C. ;
Gomez, Alvin ;
Rodriguez-Antona, Cristina .
PHARMACOLOGY & THERAPEUTICS, 2007, 116 (03) :496-526